Álvaro Gómez-Peña

Learn More
OBJECTIVE The influence of CD34+ cell dose on the outcome of allogeneic peripheral blood stem cell (PBSC) transplantation after reduced intensity conditioning (RIC) remains controversial. The impact of the number of CD34+ hematoprogenitors infused on transplant outcome and on the incidence of graft versus host disease (GVHD) was analyzed. MATERIALS AND(More)
Hematopoietic SCT (HSCT) has become an established therapy for numerous disorders of the hematopoietic system and for some solid tumors. However, owing to the high cost of the procedure, and the need for a multidisciplinary team, few centers in developing countries provide this treatment modality. In Mexico, the history of HSCT began in 1980, when the first(More)
BACKGROUND The prevalence and features of graft-versus-host disease (GVHD) in patients receiving allografts using peripheral blood stem cells (PBSCs) after a reduced-intensity conditioning (RIC) regimen are not well known. Several features of GVHD in patients at two institutions using RIC were assessed. METHODS We analysed the overall survival (OS) and(More)
  • 1